Home

DiaMedBase 

Diabetes Medicinal Plant Database

Browse    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     Plants List
Abelmoschus
Abies
Abroma
Acacia
Acanthopanax
Acer
Achillea
Achyranthes
Achyrocline
Acosmium
Acourtia
Adhatoda
Aegle
Agaricus
Aglaonema
Agrimony
Ajuga
Alchemilla
Allium
Aloe
Anacardium
Andrographis
Anemarrhena
Angylocalyx
Annona
Apocynum
Aralia
Arctium
Arctostaphylos
Areca
Arfazetin
Artemisia
Artocarpus
Asteracanthus
Astragalus
Averrhoa
Azadirachta
Azorella
 
DiaMedBase ID   DMPAc094
Medicinal Plant   Azorella compacta
Plant part(s)   Whole plant
Objective   To determine the diterpenic compounds isolated from Azorella compacta are responsible for antihyperglycemic effect in streptozotocin diabetic rats
Journal Source   Phytotherapy Research, 2005; 19(8):713-716
Title  
Experimental antihyperglycemic effect of diterpenoids of llareta Azorella compacta (Umbelliferae) Phil in rats
Authors   Nelson L. Fuentes 1, Hernan Sagua 2, Glauco Morales 3, Jorge Borquez 3, Aurelio San Martin 4, Julia Soto 5, Luis A Loyola 3
Address   1Biomedical Department, University of Antofagasta, Antofagasta, Chile 2Unit of Parasitology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile 3Laboratory of Natural Products Department of Chemistry, Faculty of Basic Sciences, University of Antofagasta, Antofagasta, Chile 4Department of Chemistry, Faculty of Sciences, University of Chile, Santiago, Chile 5Unit of Molecular Biology and Development, Clinical Laboratory Services, Faculty of Medicine, Catholic University of Chile, Santiago, Chile
Abstract   Aqueous or ethanol infusions of Azorella compacta (llareta) in common with many other plants have been used as antidiabetic in the popular medicine in the altiplanic region of Chile. In order to determine if the diterpenic compounds chemically elucidated and isolated from this plant are responsible for this effect, streptozotocin diabetic rats (507 ± 67 mg/mL glucose) were injected with two injections of diterpenic compounds mulinolic acid, azorellanol, and mulin-11,13-dien-20-oic acid at 180 mg/mL. Glycemia of animals treated with mulinolic acid and azorellanol was decreased to 243 ± 2 and 247 ± 14 mg/mL respectively, values very close to those reached by chlorpropamide injection used in controls. After 3 h treatment with mulin-11,13-dien-20-oic acid no effect was detected. The blood serum insulin in diabetic rats (146 ± 58 pg/mL) was lower than in control rats. After injection of azorellanol, insulin was elevated to 247 ± 23 pg/mL but with mulinolic acid, insulin was not changed. The antihyperglycemic effect of these compounds may explain the effectiveness of llareta in popular medicine. Because of the similarity to the hypoglycemic medication chlorpropamide, azorellanol could be acting on the cells of pancreatic islets, while mulinolic acid may act upon glucose utilization or production in the liver.
Diseases   Disease Link

 

 

 

 

 

 

       Copyright © 2006 ProGene Biosciences
            Last modified: March, 2006
             info@progenebio.in